PEG-20k Applications

PEG-20k

The major mechanism of action of PEG-20k IV solution in treating severe hypovolemic shock is to increase tissue perfusion to facilitate rapid transfer of oxygen into oxygen starved tissues and organs. Research suggest that PEG-20k’s biological mechanism is shared by other clinical events associated with traumatic shock including cardiac illness, critical illness, sepsis and vascular disease.

point
Affliction Graphic

Trauma Injury

Publications

Potential Treatment For:

Hemorrhagic Shock

1.9 M

Annual Lives Lost Worldwide

Traumatic Brain Injury

2.8 M

Injuries Annually US

point
Affliction Graphic

Cardiac Illness

Publications

Potential Treatment For:

Heart Attacks

805 K

Annually US

Congestive Heart Failure

875 K

Hospitalizations Annually US

point
Affliction Graphic

ICU/ Critical Illness

Potential Treatment For:

Sepsis

1.7 M

Annually US

Acute Respiratory Distress Syndrome

190 K

Annually US

point
Affliction Graphic

Vascular Disease

Potential Treatment For:

Peripheral Vascular Disease

8.5 M

Cases per year - US

Sickle Cell Crisis

1.2 M

Cases per year - US

Pipeline graphic

Pipeline

Perfusion Medical is conducting research and preparing for clinical trials for several key indications

Learn More